Vergote I - Search Results

1

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.

Van Nieuwenhuysen E, Busschaert P, Laenen A, Moerman P, Han SN, Neven P, Lambrechts D, Vergote I. Van Nieuwenhuysen E, et al. Among authors: vergote i. Neoplasia. 2019 Jun;21(6):582-590. doi: 10.1016/j.neo.2019.03.014. Epub 2019 May 1. Neoplasia. 2019. PMID: 31054497 Free PMC article.

2

Case report: mixed germ cell tumour of the ovary presenting as a missed abortion.

Vergote IB, Witters I, Moerman P, Timmerman D, Spitz B, Van Assche FA. Vergote IB, et al. Eur J Gynaecol Oncol. 1996;17(6):518-9. Eur J Gynaecol Oncol. 1996. PMID: 8971532 No abstract available.

3

Malignant trophoblastic disease following a twin pregnancy consisting of a complete hydatiform mole and a normal fetus and placenta. A case report.

Vandeginste S, Vergote IB, Hanssens M, Moerman P, Page G, Van Den Berghe K, Van Assche A. Vandeginste S, et al. Among authors: vergote ib. Eur J Gynaecol Oncol. 1999;20(2):105-7. Eur J Gynaecol Oncol. 1999. PMID: 10376424

4

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

5

The diagnostic problem of endometrial stromal sarcoma: report on six cases.

Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Jul;90(1):37-43. doi: 10.1016/s0090-8258(03)00207-5. Gynecol Oncol. 2003. PMID: 12821339 Review.

6

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.

Amant F, Vloeberghs V, Woestenborghs H, Moerman P, Vergote I. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Aug;90(2):372-7. doi: 10.1016/s0090-8258(03)00326-3. Gynecol Oncol. 2003. PMID: 12893202

7

Endometriosis and the development of malignant tumours of the pelvis. A review of literature.

Van Gorp T, Amant F, Neven P, Vergote I, Moerman P. Van Gorp T, et al. Among authors: vergote i. Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):349-71. doi: 10.1016/j.bpobgyn.2003.03.001. Best Pract Res Clin Obstet Gynaecol. 2004. PMID: 15157647 Review.

8

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

Amant F, Schurmans K, Steenkiste E, Verbist L, Abeler VM, Tulunay G, De Jonge E, Massuger L, Moerman P, Vergote I. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2004 Jun;93(3):680-5. doi: 10.1016/j.ygyno.2004.03.021. Gynecol Oncol. 2004. PMID: 15196864

9

Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.

Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, Van Limbergen E, Carbonez A, Van Huffel S, Ameye L, Paridaens R. Morales L, et al. Among authors: vergote i. Anticancer Drugs. 2004 Sep;15(8):753-60. doi: 10.1097/00001813-200409000-00003. Anticancer Drugs. 2004. PMID: 15494636 Clinical Trial.

10

ERBB-2 gene overexpression and amplification in uterine sarcomas.

Amant F, Vloeberghs V, Woestenborghs H, Debiec-Rychter M, Verbist L, Moerman P, Vergote I. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2004 Dec;95(3):583-7. doi: 10.1016/j.ygyno.2004.07.041. Gynecol Oncol. 2004. PMID: 15581967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters